JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib

JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2025-01
Hauptverfasser: Ceccardi, Andrea, Dameri, Martina, Ravera, Francesco, Gilardi, Nicolò, Stabile, Mario, Lombardo, Isabella, Ceresa, Davide, Colombo, Monica, Vigo, Tiziana, Cigolini, Benedetta, Rivoli, Giulia, Dragani, Matteo, Solimano, Irene, Garuti, Anna, Bellodi, Andrea, Ballestrero, Alberto, Ferrando, Lorenzo, Zoppoli, Gabriele
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title British journal of haematology
container_volume
creator Ceccardi, Andrea
Dameri, Martina
Ravera, Francesco
Gilardi, Nicolò
Stabile, Mario
Lombardo, Isabella
Ceresa, Davide
Colombo, Monica
Vigo, Tiziana
Cigolini, Benedetta
Rivoli, Giulia
Dragani, Matteo
Solimano, Irene
Garuti, Anna
Bellodi, Andrea
Ballestrero, Alberto
Ferrando, Lorenzo
Zoppoli, Gabriele
description
doi_str_mv 10.1111/bjh.19979
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3156526846</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3156526846</sourcerecordid><originalsourceid>FETCH-LOGICAL-c175t-ef567b21b533542d421a965659bae35ccdd210b0926e2293df9582034edce1d53</originalsourceid><addsrcrecordid>eNo9kMtOwzAQAC0EoqVw4AeQj3BI8dpxEh-rqjwrgcRD3CIn3lBXaVJsR9C_J9DCXlYrzc5hCDkFNoZ-LovlYgxKpWqPDEEkMuIQwz4ZMsbSCFicDciR90vGQDAJh2QgVAZxkokhebyb3HNqPdW0dDbYUtc0LNDpNXb9RYN27xiobejr7G3yRP2mMa5dIQ0OdUBDP21YUNd9tXX_3djimBxUuvZ4stsj8nI1e57eRPOH69vpZB6VkMoQYSWTtOBQSCFkzE3MQatEJlIVGoUsS2M4sIIpniDnSphKyYwzEaMpEYwUI3K-9a5d-9GhD_nK-hLrWjfYdj4X0Mt4ksVJj15s0dK13jus8rWzK-02ObD8J2DeB8x_A_bs2U7bFSs0_-RfMfEN1P1qSQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3156526846</pqid></control><display><type>article</type><title>JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ceccardi, Andrea ; Dameri, Martina ; Ravera, Francesco ; Gilardi, Nicolò ; Stabile, Mario ; Lombardo, Isabella ; Ceresa, Davide ; Colombo, Monica ; Vigo, Tiziana ; Cigolini, Benedetta ; Rivoli, Giulia ; Dragani, Matteo ; Solimano, Irene ; Garuti, Anna ; Bellodi, Andrea ; Ballestrero, Alberto ; Ferrando, Lorenzo ; Zoppoli, Gabriele</creator><creatorcontrib>Ceccardi, Andrea ; Dameri, Martina ; Ravera, Francesco ; Gilardi, Nicolò ; Stabile, Mario ; Lombardo, Isabella ; Ceresa, Davide ; Colombo, Monica ; Vigo, Tiziana ; Cigolini, Benedetta ; Rivoli, Giulia ; Dragani, Matteo ; Solimano, Irene ; Garuti, Anna ; Bellodi, Andrea ; Ballestrero, Alberto ; Ferrando, Lorenzo ; Zoppoli, Gabriele</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>ISSN: 1365-2141</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.19979</identifier><identifier>PMID: 39814683</identifier><language>eng</language><publisher>England</publisher><ispartof>British journal of haematology, 2025-01</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c175t-ef567b21b533542d421a965659bae35ccdd210b0926e2293df9582034edce1d53</cites><orcidid>0000-0002-1619-1708 ; 0000-0003-3856-7910 ; 0000-0002-5754-4856</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39814683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ceccardi, Andrea</creatorcontrib><creatorcontrib>Dameri, Martina</creatorcontrib><creatorcontrib>Ravera, Francesco</creatorcontrib><creatorcontrib>Gilardi, Nicolò</creatorcontrib><creatorcontrib>Stabile, Mario</creatorcontrib><creatorcontrib>Lombardo, Isabella</creatorcontrib><creatorcontrib>Ceresa, Davide</creatorcontrib><creatorcontrib>Colombo, Monica</creatorcontrib><creatorcontrib>Vigo, Tiziana</creatorcontrib><creatorcontrib>Cigolini, Benedetta</creatorcontrib><creatorcontrib>Rivoli, Giulia</creatorcontrib><creatorcontrib>Dragani, Matteo</creatorcontrib><creatorcontrib>Solimano, Irene</creatorcontrib><creatorcontrib>Garuti, Anna</creatorcontrib><creatorcontrib>Bellodi, Andrea</creatorcontrib><creatorcontrib>Ballestrero, Alberto</creatorcontrib><creatorcontrib>Ferrando, Lorenzo</creatorcontrib><creatorcontrib>Zoppoli, Gabriele</creatorcontrib><title>JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><issn>0007-1048</issn><issn>1365-2141</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQAC0EoqVw4AeQj3BI8dpxEh-rqjwrgcRD3CIn3lBXaVJsR9C_J9DCXlYrzc5hCDkFNoZ-LovlYgxKpWqPDEEkMuIQwz4ZMsbSCFicDciR90vGQDAJh2QgVAZxkokhebyb3HNqPdW0dDbYUtc0LNDpNXb9RYN27xiobejr7G3yRP2mMa5dIQ0OdUBDP21YUNd9tXX_3djimBxUuvZ4stsj8nI1e57eRPOH69vpZB6VkMoQYSWTtOBQSCFkzE3MQatEJlIVGoUsS2M4sIIpniDnSphKyYwzEaMpEYwUI3K-9a5d-9GhD_nK-hLrWjfYdj4X0Mt4ksVJj15s0dK13jus8rWzK-02ObD8J2DeB8x_A_bs2U7bFSs0_-RfMfEN1P1qSQ</recordid><startdate>20250115</startdate><enddate>20250115</enddate><creator>Ceccardi, Andrea</creator><creator>Dameri, Martina</creator><creator>Ravera, Francesco</creator><creator>Gilardi, Nicolò</creator><creator>Stabile, Mario</creator><creator>Lombardo, Isabella</creator><creator>Ceresa, Davide</creator><creator>Colombo, Monica</creator><creator>Vigo, Tiziana</creator><creator>Cigolini, Benedetta</creator><creator>Rivoli, Giulia</creator><creator>Dragani, Matteo</creator><creator>Solimano, Irene</creator><creator>Garuti, Anna</creator><creator>Bellodi, Andrea</creator><creator>Ballestrero, Alberto</creator><creator>Ferrando, Lorenzo</creator><creator>Zoppoli, Gabriele</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1619-1708</orcidid><orcidid>https://orcid.org/0000-0003-3856-7910</orcidid><orcidid>https://orcid.org/0000-0002-5754-4856</orcidid></search><sort><creationdate>20250115</creationdate><title>JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib</title><author>Ceccardi, Andrea ; Dameri, Martina ; Ravera, Francesco ; Gilardi, Nicolò ; Stabile, Mario ; Lombardo, Isabella ; Ceresa, Davide ; Colombo, Monica ; Vigo, Tiziana ; Cigolini, Benedetta ; Rivoli, Giulia ; Dragani, Matteo ; Solimano, Irene ; Garuti, Anna ; Bellodi, Andrea ; Ballestrero, Alberto ; Ferrando, Lorenzo ; Zoppoli, Gabriele</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c175t-ef567b21b533542d421a965659bae35ccdd210b0926e2293df9582034edce1d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ceccardi, Andrea</creatorcontrib><creatorcontrib>Dameri, Martina</creatorcontrib><creatorcontrib>Ravera, Francesco</creatorcontrib><creatorcontrib>Gilardi, Nicolò</creatorcontrib><creatorcontrib>Stabile, Mario</creatorcontrib><creatorcontrib>Lombardo, Isabella</creatorcontrib><creatorcontrib>Ceresa, Davide</creatorcontrib><creatorcontrib>Colombo, Monica</creatorcontrib><creatorcontrib>Vigo, Tiziana</creatorcontrib><creatorcontrib>Cigolini, Benedetta</creatorcontrib><creatorcontrib>Rivoli, Giulia</creatorcontrib><creatorcontrib>Dragani, Matteo</creatorcontrib><creatorcontrib>Solimano, Irene</creatorcontrib><creatorcontrib>Garuti, Anna</creatorcontrib><creatorcontrib>Bellodi, Andrea</creatorcontrib><creatorcontrib>Ballestrero, Alberto</creatorcontrib><creatorcontrib>Ferrando, Lorenzo</creatorcontrib><creatorcontrib>Zoppoli, Gabriele</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ceccardi, Andrea</au><au>Dameri, Martina</au><au>Ravera, Francesco</au><au>Gilardi, Nicolò</au><au>Stabile, Mario</au><au>Lombardo, Isabella</au><au>Ceresa, Davide</au><au>Colombo, Monica</au><au>Vigo, Tiziana</au><au>Cigolini, Benedetta</au><au>Rivoli, Giulia</au><au>Dragani, Matteo</au><au>Solimano, Irene</au><au>Garuti, Anna</au><au>Bellodi, Andrea</au><au>Ballestrero, Alberto</au><au>Ferrando, Lorenzo</au><au>Zoppoli, Gabriele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2025-01-15</date><risdate>2025</risdate><issn>0007-1048</issn><issn>1365-2141</issn><eissn>1365-2141</eissn><cop>England</cop><pmid>39814683</pmid><doi>10.1111/bjh.19979</doi><orcidid>https://orcid.org/0000-0002-1619-1708</orcidid><orcidid>https://orcid.org/0000-0003-3856-7910</orcidid><orcidid>https://orcid.org/0000-0002-5754-4856</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2025-01
issn 0007-1048
1365-2141
1365-2141
language eng
recordid cdi_proquest_miscellaneous_3156526846
source Wiley Online Library Journals Frontfile Complete
title JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T17%3A22%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=JAK2%20is%20a%20critical%20therapeutic%20target%20in%20VEXAS%20syndrome%20treated%20with%20ruxolitinib&rft.jtitle=British%20journal%20of%20haematology&rft.au=Ceccardi,%20Andrea&rft.date=2025-01-15&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.19979&rft_dat=%3Cproquest_cross%3E3156526846%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3156526846&rft_id=info:pmid/39814683&rfr_iscdi=true